Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Common Equity (2016 - 2024)

Historic Common Equity for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $79.2 billion.

  • Sanofi's Common Equity rose 123.57% to $79.2 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $79.2 billion, marking a year-over-year increase of 123.57%. This contributed to the annual value of $82.8 billion for FY2024, which is 341.27% up from last year.
  • Latest data reveals that Sanofi reported Common Equity of $79.2 billion as of Q2 2025, which was up 123.57% from $82.8 billion recorded in Q4 2024.
  • Over the past 5 years, Sanofi's Common Equity peaked at $82.8 billion during Q4 2024, and registered a low of $75.7 billion during Q2 2022.
  • Over the past 5 years, Sanofi's median Common Equity value was $78.6 billion (recorded in 2021), while the average stood at $78.4 billion.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 921.84% in 2021, then tumbled by 289.03% in 2022.
  • Sanofi's Common Equity (Quarter) stood at $78.6 billion in 2021, then decreased by 2.89% to $76.3 billion in 2022, then rose by 4.41% to $79.7 billion in 2023, then grew by 3.97% to $82.8 billion in 2024, then decreased by 4.32% to $79.2 billion in 2025.
  • Its Common Equity stands at $79.2 billion for Q2 2025, versus $82.8 billion for Q4 2024 and $78.3 billion for Q2 2024.